- Microbiome startup raises $48M for immunotherapy and malnutrition treatmentsScientists trying to understand why cancer immunotherapy works so well for some patients and not others have found a potential answer in one cancer survivor's poop. A biotech startup has studied t…Endpoints · 2mo ago↗ source
- J&J's IBD combo fails Phase 2 studies, but will move into pivotal testingJohnson & Johnson will move a treatment for inflammatory bowel disease into Phase 3 studies despite the therapy's failure in two mid-stage trials. The company said that JNJ-4804, a combinatio…Endpoints · 2mo ago↗ source
- <![CDATA[Iopofosine I 131 Follow-Up Data Show Strong Efficacy in Waldenström Macroglobulinemia]]><![CDATA[Iopofosine I 131 produced strong responses in Waldenström macroglobulinemia, according to 12-month folllow-up data from CLOVER WaM requested by the FDA.]]>